Dynamic Technology Lab’s Corbus Pharmaceuticals CRBP Stock Holding History

Dynamic Technology Lab’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-341	Closed	-$71K	–	1001
2019 Q2	$71K	Buy	+341	New	+$73K	0.01%	893
2019 Q1	–	Sell	-580	Closed	-$102K	–	1043
2018 Q4	$102K	Buy	+580	New	+$116K	0.02%	893
2018 Q1	–	Sell	-722	Closed	-$154K	–	1092
2017 Q4	$154K	Buy	+722	New	+$155K	0.03%	904
2017 Q3	–	Sell	-1,048	Closed	-$198K	–	1086
2017 Q2	$198K	Buy	+1,048	New	+$205K	0.04%	884

Other funds holding CRBP

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dynamic Technology Lab's CRBP Position: Q3 2019 in Review

Dynamic Technology Lab sold out of Corbus Pharmaceuticals (CRBP) in Q3 2019, closing a stake of 341 shares — an estimated $71K sold.

Dynamic Technology Lab first reported a position in CRBP in Q2 2017 and held it in 4 quarters. The position peaked at $198K in Q2 2017. 103 funds tracked by Wall St. Rank hold CRBP as of Q3 2019.

Dynamic Technology Lab reported no remaining Corbus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Dynamic Technology Lab sold 341 Corbus Pharmaceuticals shares in Q3 2019, an estimated $71K.
Dynamic Technology Lab first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 4 quarters.
Dynamic Technology Lab's Corbus Pharmaceuticals position peaked at $198K in Q2 2017.
103 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2019.

Based on Dynamic Technology Lab's 13F filing for Q3 2019, filed 14 Nov 2019.